Clinuvel Pharmaceuticals Ltd SEC filings CLVLF
Clinuvel Pharmaceuticals Ltd has 49 filings in SEC EDGAR's recent list, going back to May 7, 2004. Its latest annual report, Form 20-F, was filed on Oct 30, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Oct 30, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Oct 30, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Oct 30, 2026 | Oct 30, 2026 |
| 6-K | Current report (foreign issuer) | Oct 15, 2026 | Oct 15, 2026 |
| 6-K | Current report (foreign issuer) | Oct 7, 2026 | Oct 7, 2026 |
| 6-K | Current report (foreign issuer) | Oct 2, 2026 | Oct 2, 2026 |
| 6-K | Current report (foreign issuer) | Oct 1, 2026 | Oct 1, 2026 |
| 6-K | Current report (foreign issuer) | Sep 9, 2026 | Sep 8, 2026 |
| 6-K | Current report (foreign issuer) | Aug 27, 2026 | Aug 27, 2026 |
| 6-K | Current report (foreign issuer) | Aug 20, 2026 | Aug 20, 2026 |
| 6-K | Current report (foreign issuer) | Aug 12, 2026 | Aug 12, 2026 |
| 6-K | Current report (foreign issuer) | Jul 30, 2026 | Jul 30, 2026 |
| 6-K | Current report (foreign issuer) | Jul 28, 2026 | Jul 28, 2026 |
| 6-K | Current report (foreign issuer) | Jul 27, 2026 | Jul 27, 2026 |
| 6-K | Current report (foreign issuer) | Jul 23, 2026 | Jul 23, 2026 |
| 6-K | Current report (foreign issuer) | Jul 22, 2026 | Jul 21, 2026 |
| 6-K | Current report (foreign issuer) | Jul 22, 2026 | Jul 21, 2026 |
| SEC STAFF ACTION | Filing | Jul 17, 2026 | — |
| 424B3 | Prospectus | Jul 17, 2026 | — |
| CERT | Filing | Jul 17, 2026 | — |
| CORRESP | Letter to the SEC | Jul 15, 2026 | — |
| CORRESP | Letter to the SEC | Jul 9, 2026 | — |
| CORRESP | Letter to the SEC | Jul 6, 2026 | — |
| CORRESP | Letter to the SEC | Jun 15, 2026 | — |
| 20FR12B | Filing | Jun 15, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 23, 2026 | — |
| DRSLTR | Filing | Apr 17, 2026 | — |
| DRS/A | Filing | Apr 17, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2026 | — |
| DRS/A | Filing | Mar 30, 2026 | — |
| DRSLTR | Filing | Mar 27, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 19, 2026 | — |
| DRS/A | Filing | Mar 4, 2026 | — |
| DRSLTR | Filing | Mar 4, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2026 | — |
| DRS | Filing | Dec 18, 2025 | — |
| EFFECT | Filing | Aug 16, 2021 | — |
| F-6 | Filing | Aug 6, 2021 | — |
| 424B3 | Prospectus | Nov 26, 2010 | — |
| 424B3 | Prospectus | Mar 20, 2006 | — |
| SUPPL | Auto-generated paper document | May 6, 2005 | — |
| SUPPL | Auto-generated paper document | Apr 15, 2005 | — |
| SUPPL | Auto-generated paper document | Jan 5, 2005 | — |
| ARS | Annual report to shareholders | Oct 5, 2004 | Jun 30, 2004 |
| SUPPL | Auto-generated paper document | Oct 5, 2004 | — |
| SUPPL | Auto-generated paper document | Aug 23, 2004 | — |
| F-6 | Form f-6 | Jun 22, 2004 | — |
| SUPPL | Auto-generated paper document | May 7, 2004 | — |
| ARS | Annual report to shareholders | May 7, 2004 | Jun 30, 2003 |
| 12G3-2B | Auto-generated paper document | May 7, 2004 | — |
Showing 49 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- American Depositary Receipts (SIC 8880)
- Listed as
- CUVL (Nasdaq), CLVLF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Melbourne, Victoria
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1290877
- Former names
- EpiTan LTD (until Mar 20, 2006)
Other American Depositary Receipts companies
- Kongsberg Gruppen ASA/ADR KBGGY
- Sumitomo Electric Industries LTD/ADR/ SMTOY
- MTN Group LTD/ADR MTNOY
- Daiwa Securities Group Inc. DSEEY
- Yara International ASA YARIY
- Weir Group PLC/ADR WEGRY
- Pandora A/S / ADR PNDRY
- Vibra Energia S.A./ADR VBREY
Source: SEC EDGAR filings. This is company-reported data, not investment advice.